{
    "organizations": [],
    "uuid": "9896dbd91b7802c5167e5b004c71a991f7f305bd",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-gsk-ceo-says-will-take-serious-loo/brief-gsk-ceo-says-will-take-serious-look-at-major-consumer-health-assets-idUSL9N15G04O",
    "ord_in_thread": 0,
    "title": "BRIEF-GSK CEO says will take serious look at major consumer health assets",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 7 (Reuters) - Glaxosmithkline CEO Emma Walmsley tells reporters:\n* CEO SAYS OBVIOUSLY EXPECTING MORE COMPETITION IN HIV THIS YEAR\n* CEO SAYS FIRST PRIORITY IS PHARMA RESEARCH AND DEVELOPMENT, WHICH COULD INCLUDE EARLY-STAGE DRUG DEALS\n* CEO SAYS NEXT PRIORITY IS CONSUMER PUT FROM NOVARTIS, IF IT COMES\n* CEO SAYS NO COMMENT ON PFIZER CONSUMER HEALTHCARE AUCTION BUT SHOULD EXPECT GSK TO TAKE SERIOUS LOOK AT MAJOR CONSUMER ASSETS\n* CEO SAYS BIG CONSUMER HEALTH DEAL ‘NOT A NEED TO DO’\n* CEO SAYS BELIEVES SHINGRIX WILL BE BIGGEST VACCINE FOR GSK OVER MEDIUM TO LONG TERM\n* CEO SAYS ‘WE KNOW DIVIDEND MATTERS TO OUR SHAREHOLDERS’\n* CEO SAYS MOST IMPORTANT THING ON BREXIT IS TO GET A TRANSITION PERIOD OF AT LEAST 2 YEARS, SECURED BY APRIL 2018\n* CEO SAYS ON BREXIT INDUSTRY NEEDS MUTUAL RECOGNITION, CLOSE WORK WITH EMA, MINIMAL TRADE FRICTION, CONTINUED RESEARCH AND DEVELOPMENT COLLABORATION WITH EU Further company coverage: (Reporting by UK bureau)\n ",
    "published": "2018-02-07T20:49:00.000+02:00",
    "crawled": "2018-02-09T06:10:33.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "glaxosmithkline",
        "ceo",
        "emma",
        "walmsley",
        "tell",
        "reporter",
        "ceo",
        "say",
        "obviously",
        "expecting",
        "competition",
        "hiv",
        "year",
        "ceo",
        "say",
        "first",
        "priority",
        "pharma",
        "research",
        "development",
        "could",
        "include",
        "drug",
        "deal",
        "ceo",
        "say",
        "next",
        "priority",
        "consumer",
        "put",
        "novartis",
        "come",
        "ceo",
        "say",
        "comment",
        "pfizer",
        "consumer",
        "healthcare",
        "auction",
        "expect",
        "gsk",
        "take",
        "serious",
        "look",
        "major",
        "consumer",
        "asset",
        "ceo",
        "say",
        "big",
        "consumer",
        "health",
        "deal",
        "need",
        "ceo",
        "say",
        "belief",
        "shingrix",
        "biggest",
        "vaccine",
        "gsk",
        "medium",
        "long",
        "term",
        "ceo",
        "say",
        "know",
        "dividend",
        "matter",
        "shareholder",
        "ceo",
        "say",
        "important",
        "thing",
        "brexit",
        "get",
        "transition",
        "period",
        "least",
        "year",
        "secured",
        "april",
        "ceo",
        "say",
        "brexit",
        "industry",
        "need",
        "mutual",
        "recognition",
        "close",
        "work",
        "ema",
        "minimal",
        "trade",
        "friction",
        "continued",
        "research",
        "development",
        "collaboration",
        "eu",
        "company",
        "coverage",
        "reporting",
        "uk",
        "bureau"
    ]
}